Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 6, 1999, Pages 645-650

  Brasseur, Philippe ^a   Guiguemde, Robert ^b   Diallo, Samba ^c   Guiyedi, Vincent ^d   Kombila, Maryvonne ^d   Ringwald, Pascal ^e   Olliaro, Piero ^f  

^a HÔPITAL CHARLES NICOLLE   (France)

^b CENTRE MURAZ   (Burkina Faso)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^e Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Amodiaquine; Burkina Faso; Cameroon; Chemosensitivity; Chemotherapy; Chloroquine; Gabon; Malaria; Plasmodium falciparum; Senegal

Indexed keywords

AMODIAQUINE; CHLOROQUINE;

ADOLESCENT; ADULT; AFRICA; ARTICLE; BURKINA FASO; CAMEROON; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; FOLLOW UP; GABON; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; MULTICENTER STUDY; PARASITEMIA; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SENEGAL; SYMPTOM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0033385917     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90083-4     Document Type: Article

References (18)

1. Amukoye, E., Winstanley, P. A., Watkins, W. M., Snow, R. W., Hatcher, J., Mosobo, M., Ngumbao, E., Lowe, B., Ton, M., Minyiri, G. & Marsh, K. (1997). Chlorproguanil-dapsone: effective treatment for uncomplicated malaria. Antimicrobial Agents and Chemotherapy, 41, 2261-2264.
2. Brasseur, P., Kouamouo, J., Moyou-Somo, R. & Druilhe, P. (1992). Multi-drug resistant falciparum malaria in Cameroon in 1987-1988 I. Stable figures of prevalence of chloroquine and quinine resistant isolates in the original foci. American Journal of Tropical Medicine and Hygiene, 46, 1-7.
3. Brasseur, P., Agnamey, P., Same Ekobo, A., Samba, G., Favennec, L. & Kouamouo, J. (1995). Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 528-530.
4. Carme, B., Sathounkasi, C., Mbitsi, A., Ndounga, M., Gay, F., Chandenier, J., Schmitt, J. L. & Samba, G. (1991). Efficacité comparée de la chloroquine et de l'amodiaquine (25 et 35 mg/kg) chez les écoliers porteurs de P. falciparum (Brazzaville, Mars 1990). Bulletin de la Société de Pathologie Exotique, 84, 77-79.
5. Clarke, J. B., Naftel, K., Kitteringham, N. R. & Park, B. K. (1991). Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine. International Archives of Allergy and Applied Immunology, 95, 369-375.
6. Escande, C., Chevalier, P., Verdier, F. & Bourdon, R. (1990). Sensitive radioimmunoassay and enzyme-linked immunosorbent assay for the simultaneous determination of chloroquine and its metabolites in biological fluids. Journal of Pharmaceutical Sciences, 79, 23-27.
7. Maggs, J. L., Tingle, M. D., Kitteringham, N. R. & Parke, B. K. (1988). Mechanisms of formation of protein to arylamines intermediaries from amodiaquine, a myelotoxin and hepatotoxin in man. Biochemical Pharmacology, 37, 305-311.
8. Mount, D. L., Nahlen, B. L., Parchen, L. C. & Churchill, F. C. (1989). Adaptations of the Saker-Salomon test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bulletin of the World Health Organization, 67, 295-300.
9. Olliaro, P., Nevill, C., Ringwald, P, Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 438, 1196-1201.
10. Phillips-Howard, P. A. & Bjorkman, A. B. (1990). Ascertain of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs. Bulletin of the World Health Organization, 68, 493-504.
11. Pinichpongse, S., Doberstyn, E. B., Cullen, J. R., Yisunsri, L., Thongsombun, Y. & Thimarsan, K. (1982). An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-1981. Bulletin of the World Health Organization, 60, 907-912.
12. Sokhna, C. S., Molez, J. F., Ndiaye, P., Sane, B. & Trape, J. F. (1997). Tests in vivo de chimiosensibilité de Plasmodium falciparum à la chloroquine au Sénégal: évolution de la résistance et estimation de l'efficacité thérapeutique. Bulletin de la Société de Pathologie Exotique, 90, 83-89.
13. Sowunmi, A. & Oduola, A. M. (1998). Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine. European Journal of Clinical Pharmacology, 54, 221-226.
14. Spencer, H. C., Watkins, W. W., Sixsmith, D. G. & Koech, D. K. (1986). Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 201-203.
15. White, N. J. (1992). Antimalarial drug resistance: the pace quickens. Journal of Antimicrobial Chemotherapy, 30, 571-585.
16. WHO (1990). Practical Chemotherapy of Malaria. Geneva: World Health Organization, Technical Report Series, no. 805.
17. WHO (1996a). Management of uncomplicated malaria and the use of antimalarial drugs for the protection of travellers. Geneva: World Health Organization. WHO/MAL/96, 1075, 19-22.
18. WHO (1996b). Assessment of therapeutic efficacy of antimalarial drugs in areas with intense transmission. Geneva: World Health Organization. WHO/MAL/96,1077, 11-15.